Kyverna Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts that cover Kyverna Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $15.5, which forecasts a 310.05% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $24.

Price Target: $15.5 (+310.05%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$15.5	$20	$24
Change	+32.28%	+310.05%	+429.10%	+534.92%

* Price targets were last updated on May 27, 2025.

Analyst Ratings

The average analyst rating for Kyverna Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	1	1	2	2	2	2
Buy	3	3	3	3	3	3
Hold	1	1	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sami Corwin William Blair	William Blair	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Aug 20, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Buy Upgrades $4 → $5	Hold → Strong Buy	Upgrades	$4 → $5	+32.28%	May 27, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains $6 → $4	Hold	Maintains	$6 → $4	+5.82%	Apr 3, 2025
Michael Ulz Morgan Stanley	Morgan Stanley	Buy Maintains $40 → $20	Buy	Maintains	$40 → $20	+429.10%	Apr 1, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains $7 → $6	Hold	Maintains	$7 → $6	+58.73%	Nov 20, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-3.88

from -3.33

EPS Next Year

-3.66

from -3.88

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	5.66M	7.03M	-	-	-	-	15.42M
Revenue Growth	-	24.20%	-	-	-	-	-
EPS	-99.10	-63.43	-89.61	-3.33	-3.88	-3.66	-3.78
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	9	9	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-3.52	-3.11
Avg	-3.88	-3.66
Low	-4.19	-4.13

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.